Terms: = Lung cancer AND COX6C, P09669, 1345, ENSG00000164919 AND Prognosis
5 results:
1. cox6c expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma.
Liu S; Shao F; Wang Y; Zhang Y; Yu H; Zhang N; He L; Kong Q; Jiang H; Dong Z
Cell Death Dis; 2024 Jan; 15(1):74. PubMed ID: 38242874
[TBL] [Abstract] [Full Text] [Related]
2. Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell lung cancer.
Chen Y; Wen S; Xia J; Du X; Wu Y; Pan B; Zhu W; Shen B
Front Immunol; 2021; 12():672271. PubMed ID: 34054853
[TBL] [Abstract] [Full Text] [Related]
3. Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD.
Dong W; Du Y; Ma S
Int J Chron Obstruct Pulmon Dis; 2018; 13():3805-3812. PubMed ID: 30538442
[TBL] [Abstract] [Full Text] [Related]
4. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
[TBL] [Abstract] [Full Text] [Related]
5. Japanese lung cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
[TBL] [Abstract] [Full Text] [Related]
